N-(7-hydroxynaphthalen-1-yl)biphenyl-4-sulfonamide

ID: ALA2322452

PubChem CID: 71716808

Max Phase: Preclinical

Molecular Formula: C22H17NO3S

Molecular Weight: 375.45

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=S(=O)(Nc1cccc2ccc(O)cc12)c1ccc(-c2ccccc2)cc1

Standard InChI:  InChI=1S/C22H17NO3S/c24-19-12-9-18-7-4-8-22(21(18)15-19)23-27(25,26)20-13-10-17(11-14-20)16-5-2-1-3-6-16/h1-15,23-24H

Standard InChI Key:  RZNLXROGNQIVPL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    3.5562  -14.5902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3744  -14.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7597  -13.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3244  -13.1494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5059  -13.1821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1261  -13.9027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5805  -13.8129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0125  -14.5143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8322  -14.4866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2173  -13.7582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7777  -13.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9603  -13.0939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0378  -13.7299    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.4165  -14.4479    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0096  -12.9123    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2318  -14.4705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6124  -15.1949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4310  -15.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8664  -14.5321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7201  -13.2830    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6591  -13.7782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4756  -13.8052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9055  -13.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5199  -12.3925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7000  -12.3694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2739  -13.0627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3113  -11.6506    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
 10 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 22  1  0
 21 16  1  0
 13 20  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 21  2  0
 25 27  1  0
M  END

Alternative Forms

Associated Targets(Human)

UQCRB Tbio Cytochrome b-c1 complex subunit 7 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

J774 (3120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 375.45Molecular Weight (Monoisotopic): 375.0929AlogP: 5.01#Rotatable Bonds: 4
Polar Surface Area: 66.40Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.54CX Basic pKa: CX LogP: 4.79CX LogD: 4.59
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -0.75

References

1. Greig IR, Coste E, Ralston SH, van 't Hof RJ..  (2013)  Development of triarylsulfonamides as novel anti-inflammatory agents.,  23  (3): [PMID:23265887] [10.1016/j.bmcl.2012.11.067]
2. Jung HJ, Cho M, Kim Y, Han G, Kwon HJ..  (2014)  Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads.,  57  (19): [PMID:25244355] [10.1021/jm500863j]

Source